Beranda › Kanker Paru Non-Sel Kecil › New York › Greenburgh
Uji klinis Kanker Paru Non-Sel Kecil di Greenburgh, NY
28 studi untuk Kanker Paru Non-Sel Kecil mencari peserta di lokasi sekitar Greenburgh (dalam radius sekitar 30 mil). Buka studi untuk melihat kriteria peserta dan cara menghubungi tim studi.
Teks studi resmi (Bahasa Inggris)
Merekrut peserta untuk studi di sini? Tampilkan di bagian atas halaman ini — $99 selama 30 hari →
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
Menerima pesertaFase 3
- Phelps Memorial Hospital Center, Sleepy Hollow · 4 mi jauhnya
- Dickstein Cancer Treatment Center, White Plains · 4 mi jauhnya
A Study of Targeted Post-Surgery Radiation Therapy for Non-Small Cell Lung Cancer With Remaining Lymph Node Cancer After Treatment
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
Menerima pesertaFase 3
- Westchester Medical Center ( Site 0196), Valhalla · 5 mi jauhnya
A Safety and Efficacy Study of EIK1001 in Combination With Pembrolizumab and Chemotherapy in Participants With Stage 4 Non-Small Cell Lung Cancer.
Menerima pesertaFase 2/3
- White Plains Hospital, White Plains · 4 mi jauhnya
A Clinical Trial of Adjuvant Intismeran (V940) With or Without Pembrolizumab Coformulated With Berahyaluronidase Alfa (MK-3475A) in High-Risk Stage I Non-Small Cell Lung Cancer (V940-014)
Menerima pesertaFase 3
- White Plains Hospital ( Site 3213), White Plains · 4 mi jauhnya
A Study to Learn About the Study Medicine Called PF-08046054/SGN-PDL1V Versus Docetaxel in Adult Participants With Previously-Treated Programmed Cell Death Ligand 1 (PD-L1) Positive Non-Small-Cell Lung Cancer (NSCLC)
Menerima pesertaFase 3
- White Plains Hospital, White Plains · 4 mi jauhnya
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
Menerima pesertaFase 3
- White Plains Hospital ( Site 0091), White Plains · 4 mi jauhnya
Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Menerima pesertaFase 3
- Hematology Oncology Associates of Rockland, Nyack · 6 mi jauhnya
This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
Menerima pesertaFase 3
- Hematology Oncology Associates of Rockland, Nyack · 6 mi jauhnya
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
Menerima pesertaFase 3
- White Plains Hospital, White Plains · 4 mi jauhnya
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
Menerima pesertaFase 2/3
- White Plains Hospital, White Plains · 4 mi jauhnya
A Study of Tepotinib and Ivonescimab in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
A Study of BIO 300 and Thoracic Radiation Therapy in People With Non-Small Cell Lung Cancer and Interstitial Lung Disease
Menerima pesertaFase 2
- Memorial Sloan Kettering Westchester (Limited Protocol Activities), East White Plains · 5 mi jauhnya
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
Using Urine Samples to Identify Lung Cancer
Menerima pesertaStudi observasionalSukarelawan sehat diterima
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Osimertinib Alone or With Chemotherapy for EGFR-Mutant Lung Cancers
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
A Study of Radiation Therapy to Treat Solid Tumor Cancer That Has Spread to Soft Tissue
Menerima peserta
- Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale · 9 mi jauhnya
Testing Proton Craniospinal Radiation Therapy Versus the Usual Radiation Therapy for Leptomeningeal Metastasis, RADIATE-LM Trial
Menerima pesertaFase 3
- Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
Cabozantinib in Patients With RET Fusion-Positive Advanced Non-Small Cell Lung Cancer and Those With Other Genotypes: ROS1 or NTRK Fusions or Increased MET or AXL Activity
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
A Study of Ivonescimab in Combination With Dato-DXd or Osimertinib in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Extracellular Vesicles and Particles (EVP) as Biomarkers of Recurrence in Non-Small Cell Lung Cancer
Menerima pesertaStudi observasional
- Memorial Sloan Kettering Bergen (Consent Only), Montvale · 9 mi jauhnya
A Study of Ivonescimab in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
A Study of Targeted Radiation Therapy in People With Non-Small Cell Lung Cancer (NSCLC)
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen (All protocol activities), Montvale · 9 mi jauhnya
Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has a MET Exon 14 Skipping Gene Change (An Expanded Lung-MAP Treatment Trial)
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
A Study of Ivonescimab, Chemotherapy, and Stereotactic Radiosurgery for People With Non-Small Cell Lung Cancer
Menerima pesertaFase 1/2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Using E-Nose Technology to Track Treatment Response in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen (All Protocol Activities), Montvale · 9 mi jauhnya
Investigating the Effectiveness of Stereotactic Body Radiotherapy (SBRT) in Addition to Standard of Care Treatment for Cancer That Has Spread Beyond the Original Site of Disease
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen, Montvale · 9 mi jauhnya
A Study of Trastuzumab Deruxtecan in People With Non-Small Cell Lung Cancer
Menerima pesertaFase 2
- Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · 9 mi jauhnya
GEMINI-NSCLC: NSCLC Biomarker Study
Menerima pesertaStudi observasional
- White Plains Hospital, White Plains · 4 mi jauhnya
Uji klinis Kanker Paru Non-Sel Kecil di kota lain
- Houston, TX145 studi
- New York City, NY121 studi
- Arlington, VA104 studi
- Nashville, TN97 studi
- Boston, MA90 studi
- Los Angeles, CA87 studi
- St. Louis, MO73 studi
- Chicago, IL61 studi
- Baltimore, MD60 studi
- San Antonio, TX59 studi
- Columbus, OH57 studi
- Washington, DC55 studi
Studi lain di Greenburgh
- Kanker Payudara42 studi
- Leukemia Mieloid Akut18 studi
- Kanker Prostat17 studi
- Kanker (semua jenis)17 studi
- Kanker Paru17 studi
- Mieloma Multipel13 studi
- Kanker Kolorektal11 studi
- Kanker Metastatik11 studi
- Kanker Endometrium11 studi
- Kanker Kandung Kemih10 studi
- Limfoma9 studi
- Karsinoma Sel Skuamosa Kepala dan Leher9 studi
Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.